Exhibit 99.1
NOTICE DECLARING INTENTION TO BE QUALIFIED
UNDER NATIONAL INSTRUMENT 44-101
SHORT FORM PROSPECTUS DISTRIBUTIONS (“NI 44-101”)
May 29, 2013
To: | Autorité des marchés financiers, as notice regulator, and each of the other securities regulators in the provinces of Canada where the Issuer is a reporting issuer |
Acasti Pharma Inc. (the “Issuer”) intends to be qualified to file a short form prospectus under NI 44-101. The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuer’s intent to file a short form prospectus, to enter into any particular financing or transaction or to become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer.
ACASTI PHARMA INC. | |||
By: | (signed) Xavier Harland | ||
Xavier Harland | |||
Chief Financial Officer |